Triose phosphate isomerase from the blood fluke Schistosoma mansoni: Biochemical characterisation of a potential drug and vaccine target

FEBS Letters

Volumn 587, Issue 21, 2013, Pages 3422-3427

  Zinsser, Veronika L ^a   Farnell, Edward ^b   Dunne, David W ^b   Timson, David J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bilharzia; Blood fluke; Glycolytic enzyme; Schistosomiasis; Vaccine target

Indexed keywords

DIHYDROXYACETONE PHOSPHATE; DIMER; EPITOPE; GLYCERALDEHYDE 3 PHOSPHATE; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; GEL FILTRATION; MICHAELIS MENTEN KINETICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN STABILITY; SCHISTOSOMA MANSONI; STEADY STATE; THERMOSTABILITY;

BILHARZIA; BLOOD FLUKE; GLYCOLYTIC ENZYME; SCHISTOSOMIASIS; VACCINE TARGET;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, HELMINTH; DIHYDROXYACETONE PHOSPHATE; EPITOPES; GLYCERALDEHYDE 3-PHOSPHATE; HUMANS; KINETICS; MODELS, MOLECULAR; SCHISTOSOMA MANSONI; TRIOSE-PHOSPHATE ISOMERASE;

SCHISTOSOMA MANSONI; SCHISTOSOMATIDAE; VERMES;

EID: 84886242037     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.09.022     Document Type: Article

References (67)

1. B. Gryseels, K. Polman, J. Clerinx, and L. Kestens Human schistosomiasis Lancet 368 2006 1106 1118
2. D. Humphries, S. Nguyen, D. Boakye, M. Wilson, and M. Cappello The promise and pitfalls of mass drug administration to control intestinal helminth infections Curr. Opin. Infect. Dis. 25 2012 584 589
3. W. Wang, L. Wang, and Y.S. Liang Susceptibility or resistance of praziquantel in human schistosomiasis: a review Parasitol. Res. 111 2012 1871 1877
4. P.G. Fallon, and M.J. Doenhoff Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific Am. J. Trop. Med. Hyg. 51 1994 83 88
5. V. Srinivasan, and H.J. Morowitz Ancient genes in contemporary persistent microbial pathogens Biol. Bull. 210 2006 1 9
6. F. Orosz, J. Olah, and J. Ovadi Triosephosphate isomerase deficiency: new insights into an enigmatic disease Biochim. Biophys. Acta 1792 2009 1168 1174
7. F. Orosz, J. Olah, and J. Ovadi Triosephosphate isomerase deficiency: facts and doubts IUBMB Life 58 2006 703 715
8. I.O. Daar, P.J. Artymiuk, D.C. Phillips, and L.E. Maquat Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme Proc. Natl. Acad. Sci. USA 83 1986 7903 7907
9. J.L. Seigle, A.M. Celotto, and M.J. Palladino Degradation of functional triose phosphate isomerase protein underlies sugarkill pathology Genetics 179 2008 855 862
10. M. Ralser, G. Heeren, M. Breitenbach, H. Lehrach, and S. Krobitsch Triose phosphate isomerase deficiency is caused by altered dimerization - not catalytic inactivity - of the mutant enzymes PLoS ONE 1 2006 e30
11. J. Olah, F. Orosz, L.G. Puskas, L. Hackler Jr, M. Horanyi, L. Polgar, S. Hollan, and J. Ovadi Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels Biochem. J. 392 2005 675 683
12. S.L. Hrizo, I.J. Fisher, D.R. Long, J.A. Hutton, Z. Liu, and M.J. Palladino Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency Neurobiol. Dis. 54 2013 289 296
13. R. Bonnet, S. Pavlovic, J. Lehmann, and H. Rommelspacher The strong inhibition of triosephosphate isomerase by the natural beta-carbolines may explain their neurotoxic actions Neuroscience 127 2004 443 453
14. C. Shoemaker, A. Gross, A. Gebremichael, and D. Harn CDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase Proc. Natl. Acad. Sci. USA 89 1992 1842 1846
15. D.A. Harn, W. Gu, L.D. Oligino, M. Mitsuyama, A. Gebremichael, and D. Richter A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase J. Immunol. 148 1992 562 567
16. M.D. Wright, K.M. Davern, and G.F. Mitchell The functional and immunological significance of some schistosome surface molecules Parasitol. Today 7 1991 56 58
17. B. Chen, and J.F. Wen The adaptive evolution divergence of triosephosphate isomerases between parasitic and free-living flatworms and the discovery of a potential universal target against flatworm parasites Parasitol. Res. 109 2011 283 289
18. F. Guillou, E. Roger, Y. Mone, A. Rognon, C. Grunau, A. Theron, G. Mitta, C. Coustau, and B.E. Gourbal Excretory-secretory proteome of larval Schistosoma mansoni and Echinostoma caproni, two parasites of Biomphalaria glabrata Mol. Biochem. Parasitol. 155 2007 45 56
19. R.A. Wilson Proteomics at the schistosome-mammalian host interface: any prospects for diagnostics or vaccines? Parasitology 139 2012 1178 1194
20. S. Braschi, R.S. Curwen, P.D. Ashton, S. Verjovski-Almeida, and A. Wilson The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction Proteomics 6 2006 1471 1482
21. J. Karkowska-Kuleta, S. Kedracka-Krok, M. Rapala-Kozik, W. Kamysz, S. Bielinska, A. Karafova, and A. Kozik Molecular determinants of the interaction between human high molecular weight kininogen and Candida albicans cell wall: identification of kininogen-binding proteins on fungal cell wall and mapping the cell wall-binding regions on kininogen molecule Peptides 32 2011 2488 2496
22. H. Furuya, and R. Ikeda Interaction of triosephosphate isomerase from Staphylococcus aureus with plasminogen Microbiol. Immunol. 55 2011 855 862
23. H. Furuya, and R. Ikeda Interaction of triosephosphate isomerase from the cell surface of Staphylococcus aureus and α-(1 → 3)-mannooligosaccharides derived from glucuronoxylomannan of Cryptococcus neoformans Microbiology 155 2009 2707 2713
24. L.A. Pereira, S.N. Bao, M.S. Barbosa, J.L. da Silva, M.S. Felipe, J.M. de Santana, M.J. Mendes-Giannini, and C.M. de Almeida Soares Analysis of the Paracoccidioides brasiliensis triosephosphate isomerase suggests the potential for adhesin function FEMS Yeast Res. 7 2007 1381 1388
25. Y. Zhu, F. Lu, Y. Dai, X. Wang, J. Tang, S. Zhao, C. Zhang, H. Zhang, S. Lu, and S. Wang Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines Vaccine 28 2010 5347 5355
26. Y. Dai, Y. Zhu, D.A. Harn, X. Wang, J. Tang, S. Zhao, F. Lu, and X. Guan DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica Clin. Vaccine Immunol. 16 2009 1796 1803
27. A.A. Da'dara, Y.S. Li, T. Xiong, J. Zhou, G.M. Williams, D.P. McManus, Z. Feng, X.L. Yu, D.J. Gray, and D.A. Harn DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo Vaccine 26 2008 3617 3625
28. Y. Zhu, J. Si, D.A. Harn, M. Xu, J. Ren, C. Yu, Y. Liang, X. Yin, W. He, and G. Cao Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection Parasitology 132 2006 67 71
29. Y. Zhu, J. Si, D.A. Harn, C. Yu, Y. Liang, J. Ren, X. Yin, W. He, and W. Hua The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice Southeast Asian J. Trop. Med. Public Health 35 2004 518 522
30. Y. Zhu, J. Si, D.A. Ham, C. Yu, W. He, W. Hua, X. Yin, Y. Liang, M. Xu, and R. Xu The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase Southeast Asian J. Trop. Med. Public Health 33 2002 207 213
31. S.A. Victor, M.F. Yolanda, Z.C. Araceli, J. Lucia, and L. Abraham Characterization of a monoclonal antibody that specifically inhibits triosephosphate isomerase activity of Taenia solium Exp. Parasitol. 134 2013 495 503
32. L. Saramago, M. Franceschi, C. Logullo, A. Masuda, S. Vaz Ida, S.E. Farias, and J. Moraes Inhibition of Enzyme Activity of Rhipicephalus (Boophilus) microplus triosephosphate isomerase and BME26 cell growth by monoclonal antibodies Int. J. Mol. Sci. 13 2012 13118 13133
33. A.A. Cortes-Figueroa, A. Perez-Torres, N. Salaiza, N. Cabrera, A. Escalona-Montano, A. Rondan, M. Aguirre-Garcia, A. Gomez-Puyou, R. Perez-Montfort, and I. Becker A monoclonal antibody that inhibits Trypanosoma cruzi growth in vitro and its reaction with intracellular triosephosphate isomerase Parasitol. Res. 102 2008 635 643
34. J.M. Fitzpatrick, E. Peak, S. Perally, I.W. Chalmers, J. Barrett, T.P. Yoshino, A.C. Ivens, and K.F. Hoffmann Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses PLoS Negl. Trop. Dis. 3 2009 e543
35. S. Harper, and D.W. Speicher Purification of proteins fused to glutathione S-transferase Methods Mol. Biol. 681 2011 259 280
36. C.M. Fitzsimmons, R. McBeath, S. Joseph, F.M. Jones, K. Walter, K.F. Hoffmann, H.C. Kariuki, J.K. Mwatha, G. Kimani, N.B. Kabatereine, B.J. Vennervald, J.H. Ouma, and D.W. Dunne Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: molecular structure and patterns of in vivo exposure Int. Arch. Allergy Immunol. 142 2007 40 50
37. C.M. Fitzsimmons, F.M. Jones, A. Stearn, I.W. Chalmers, K.F. Hoffmann, J. Wawrzyniak, S. Wilson, N.B. Kabatereine, and D.W. Dunne The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses PLoS Negl. Trop. Dis. 6 2012 e1593
38. L.A. Kelley, and M.J. Sternberg Protein structure prediction on the web: a case study using the Phyre server Nat. Protoc. 4 2009 363 371
39. C. Rodriguez-Almazan, R. Arreola, D. Rodriguez-Larrea, B. Aguirre-Lopez, M.T. de Gomez-Puyou, R. Perez-Montfort, M. Costas, A. Gomez-Puyou, and A. Torres-Larios Structural basis of human triosephosphate isomerase deficiency: mutation E104D is related to alterations of a conserved water network at the dimer interface J. Biol. Chem. 283 2008 23254 23263
40. E. Krieger, K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson, M. Tyka, D. Baker, and K. Karplus Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8 Proteins 77 Suppl. 9 2009 114 122
41. M.D. Partis, D.G. Griffiths, G.C. Roberts, and R.D. Beechey Cross-linking of protein by ω-maleimido alkanoyl N-hydroxysuccinimido esters J. Protein Chem. 2 1983 263 277
42. V.L. Zinsser, E.M. Hoey, A. Trudgett, and D.J. Timson Triose phosphate isomerase from the liver fluke Fasciola hepatica Biochimie 2013 10.1016/j.biochi.2013.08.014 in press
43. U.B. Ericsson, B.M. Hallberg, G.T. Detitta, N. Dekker, and P. Nordlund Thermofluor-based high-throughput stability optimization of proteins for structural studies Anal. Biochem. 357 2006 289 298
44. R.A. Durst, and B.R. Staples Tris/tris-HCl: a standard buffer for use in the physiologic pH range Clin. Chem. 18 1972 206 208
45. B. Plaut, and J.R. Knowles PH-dependence of the triose phosphate isomerase reaction Biochem. J. 129 1972 311 320
46. A.M. Lambeir, F.R. Opperdoes, and R.K. Wierenga Kinetic properties of triose-phosphate isomerase from Trypanosoma brucei brucei. A comparison with the rabbit muscle and yeast enzymes Eur. J. Biochem. 168 1987 69 74
47. J. Moraes, R. Arreola, N. Cabrera, L. Saramago, D. Freitas, A. Masuda, I. da Silva Vaz Jr.; M. Tuena de Gomez-Puyou, R. Perez-Montfort, A. Gomez-Puyou, and C. Logullo Structural and biochemical characterization of a recombinant triosephosphate isomerase from Rhipicephalus (Boophilus) microplus Insect Biochem. Mol. Biol. 41 2011 400 409
48. D. Knobeloch, A. Schmidt, P. Scheerer, N. Krauss, H. Wessner, C. Scholz, G. Kuttner, T. von Rintelen, A. Wessel, and W. Hohne A coleopteran triosephosphate isomerase: X-ray structure and phylogenetic impact of insect sequences Insect Mol. Biol. 19 2010 35 48
49. N. Cabrera, G. Hernandez-Alcantara, G. Mendoza-Hernandez, A. Gomez-Puyou, and R. Perez-Montfort Key residues of loop 3 in the interaction with the interface residue at position 14 in triosephosphate isomerase from Trypanosoma brucei Biochemistry 47 2008 3499 3506
50. A. Rodriguez-Romero, A. Hernandez-Santoyo, L. del Pozo Yauner, A. Kornhauser, and D.A. Fernandez-Velasco Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica J. Mol. Biol. 322 2002 669 675
51. A. Tellez-Valencia, S. Avila-Rios, R. Perez-Montfort, A. Rodriguez-Romero, M. Tuena de Gomez-Puyou, F. Lopez-Calahorra, and A. Gomez-Puyou Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi Biochem. Biophys. Res. Commun. 295 2002 958 963
52. K. Maithal, G. Ravindra, H. Balaram, and P. Balaram Inhibition of Plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. Electrospray ionization mass spectrometric analysis of differential cysteine reactivities J. Biol. Chem. 277 2002 25106 25114
53. G. Garza-Ramos, N. Cabrera, E. Saavedra-Lira, M. Tuena de Gomez-Puyou, P. Ostoa-Saloma, R. Perez-Montfort, and A. Gomez-Puyou Sulfhydryl reagent susceptibility in proteins with high sequence similarity - triosephosphate isomerase from Trypanosoma brucei, Trypanosoma cruzi and Leishmania mexicana Eur. J. Biochem. 253 1998 684 691
54. S. Enriquez-Flores, A. Rodriguez-Romero, G. Hernandez-Alcantara, De. la Mora-De, I. la Mora, P. Gutierrez-Castrellon, K. Carvajal, G. Lopez-Velazquez, and H. Reyes-Vivas Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer Mol. Biochem. Parasitol. 157 2008 179 186
55. S. Enriquez-Flores, A. Rodriguez-Romero, G. Hernandez-Alcantara, J. Oria-Hernandez, P. Gutierrez-Castrellon, G. Perez-Hernandez, I. de la Mora, A. Castillo-Villanueva, I. Garcia-Torres, S.T. Mendez, S. Gomez-Manzo, A. Torres-Arroyo, G. Lopez-Velazquez, and H. Reyes-Vivas Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design Proteins 79 2011 2711 2724
56. G. Hernandez-Alcantara, A. Torres-Larios, S. Enriquez-Flores, I. Garcia-Torres, A. Castillo-Villanueva, S.T. Mendez, I. de la Mora, S. Gomez-Manzo, A. Torres-Arroyo, G. Lopez-Velazquez, H. Reyes-Vivas, and J. Oria-Hernandez Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region PLoS ONE 8 2013 e69031
57. T.J. McCorvie, Y. Liu, A. Frazer, T.J. Gleason, J.L. Fridovich-Keil, and D.J. Timson Altered cofactor binding affects stability and activity of human UDP-galactose 4′-epimerase: implications for type III galactosemia Biochim. Biophys. Acta 1822 2012 1516 1526
58. T.J. McCorvie, T.J. Gleason, J.L. Fridovich-Keil, and D.J. Timson Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia Biochim. Biophys. Acta 1832 2013 1279 1293
59. S.S. Ray, H. Balaram, and P. Balaram Unusual stability of a multiply nicked form of Plasmodium falciparum triosephosphate isomerase Chem. Biol. 6 1999 625 637
60. H. Reyes-Vivas, E. Martinez-Martinez, G. Mendoza-Hernandez, G. Lopez-Velazquez, R. Perez-Montfort, M. Tuena de Gomez-Puyou, and A. Gomez-Puyou Susceptibility to proteolysis of triosephosphate isomerase from two pathogenic parasites: characterization of an enzyme with an intact and a nicked monomer Proteins 48 2002 580 590
61. J. Olah, F. Orosz, G.M. Keseru, Z. Kovari, J. Kovacs, S. Hollan, and J. Ovadi Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease Biochem. Soc. Trans. 30 2002 30 38
62. J.C. Williams, J.P. Zeelen, G. Neubauer, G. Vriend, J. Backmann, P.A. Michels, A.M. Lambeir, and R.K. Wierenga Structural and mutagenesis studies of Leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power Protein Eng. 12 1999 243 250
63. W. Sun, S. Liu, P.J. Brindley, and D.P. McManus Bacterial expression and characterization of functional recombinant triosephosphate isomerase from Schistosoma japonicum Protein Expr. Purif. 17 1999 410 413
64. A. Dabrowska, I. Kamrowska, and T. Baranowski Purification, crystallization and properties of triosephosphate isomerase from human skeletal muscle Acta Biochim. Pol. 25 1978 247 256
65. S.K. Singh, K. Maithal, H. Balaram, and P. Balaram Synthetic peptides as inactivators of multimeric enzymes: inhibition of Plasmodium falciparum triosephosphate isomerase by interface peptides FEBS Lett. 501 2001 19 23
66. G. Alvarez, J. Martinez, B. Aguirre-Lopez, N. Cabrera, L. Perez-Diaz, M.T. Gomez-Puyou, A. Gomez-Puyou, R. Perez-Montfort, B. Garat, A. Merlino, M. Gonzalez, and H. Cerecetto New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition J. Enzyme Inhib. Med. Chem. 2013 10.3109/14756366.2013.765415 in press
67. V. Olivares-Illana, A. Rodriguez-Romero, I. Becker, M. Berzunza, J. Garcia, R. Perez-Montfort, N. Cabrera, F. Lopez-Calahorra, M.T. de Gomez-Puyou, and A. Gomez-Puyou Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi PLoS Negl. Trop. Dis. 1 2007 e1